SBC Medical Group Holdings Inc. (NASDAQ: SBC), a Japanese operator of aesthetic medical clinics, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, signaling its official foray into the American market. The partnership, announced late last month, combines SBC's operational expertise and global network with OrangeTwist's 24 locations across six U.S. states specializing in non-invasive treatments such as injectables, laser therapies, and body contouring.
The medical aesthetics industry is projected to grow from $34 billion to $48 billion by 2030, driven by demand for low-risk, minimally invasive procedures and an aging U.S. population. SBC estimates the market offers significant "white space" opportunities in underserved cities, which the partnership aims to capture through new clinic openings and first-mover advantages. Stephen Rodgers, global head of planning and strategy at SBC Medical, told Benzinga that the company plans further strategic investments in the U.S., seeking local partners that align with its mission and can scale.
Beyond aesthetics, SBC is positioning itself in the longevity industry, which Gabelli Research values at $85 billion in 2025 and expects to surpass $120 billion by 2030. Key trends include AI-powered diagnostics, GLP-1 weight-loss drugs, and regenerative therapies like stem cells—areas where SBC plans to leverage its infrastructure. The company also aims to replicate its partnership model across Asia, targeting Japan, Thailand, and Singapore to standardize high-quality, cost-efficient services.
OrangeTwist, backed by healthcare-focused investors Hildred Capital and Athyrium Capital, will benefit from SBC's advanced management systems integrating procurement, clinical workflows, and real-time KPI tracking. The partnership includes joint development of branded products and cross-selling in each other's spas. SBC's global strategy rests on partnering with high-performing regional operators, deploying its expertise for operational efficiencies, and securing first-mover advantages.
As the U.S. and global markets for non-invasive aesthetics and longevity services expand, SBC Medical Group is leveraging its OrangeTwist investment to build a trusted global brand. For more information, visit SBC Medical's website.
